Associazione ossicodone/naloxone per il trattamento del dolore oncologico severo - Combination of oxycodone/naloxone for severe oncologic pain treatment
From February to April 2011, 46 patients (27 male and 19 female) suffering from different cancer pain were treated with an association of oxycodone/naloxone. The pain intensity of each patient was assessed by the visual analogue scale (VAS). The measurements were taken at T0 - T15 - T30 - T45 -T60 a...
Main Author: | Paolo Desio |
---|---|
Format: | Article |
Language: | English |
Published: |
Publiediting
2011-09-01
|
Series: | Pathos |
Subjects: | |
Online Access: | https://www.pathos-journal.com/page_60.html |
Similar Items
-
Combination of oxycodone/naloxone for severe oncologic pain treatment
by: P. Desio
Published: (2011-09-01) -
Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial
by: Kyung-Hee Lee, et al.
Published: (2017-09-01) -
Treating acute pain with ossicodone/naloxone in Intensive Care Unit: case report of lower limbs compartment syndrome
by: Antonio Galzerano, et al.
Published: (2014-11-01) -
Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study
by: Guerriero F, et al.
Published: (2016-04-01) -
Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone
by: de Biase S, et al.
Published: (2016-02-01)